Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Red light therapy may ease leg pain in peripheral artery disease by improving circulation through vasodilation, boosting cellular energy and supporting tissue repair while reducing inflammation.
Several factors including device selection, wavelength, treatment parameters and safety considerations can affect results. See below for complete details on protocols, evidence and next steps.
Peripheral artery disease (PAD) affects millions of people worldwide. It occurs when plaque buildup narrows arteries in the legs, reducing blood flow and causing pain, cramping or heaviness—especially during walking or exercise. Red light therapy (RLT) has emerged as a non-invasive approach that may help ease leg pain by boosting circulation and supporting cellular repair. Below, we'll explore what PAD is, how RLT works, the evidence behind its use, and practical guidance for those considering this approach.
PAD—sometimes called arteriosclerosis obliterans—happens when fatty deposits (plaque) accumulate on the artery walls. This leads to:
If you're experiencing any of these warning signs, Ubie's free AI-powered Arteriosclerosis Obliterans symptom checker can help you understand your symptoms and provide personalized guidance on when to seek care.
Left untreated, PAD can increase the risk of heart attack, stroke or serious limb complications. Early diagnosis and lifestyle modifications are essential.
Red light therapy (RLT), also known as low-level laser therapy (LLLT) or photobiomodulation, uses specific wavelengths of red and near-infrared light (600–900 nm) to stimulate cellular function. Originally developed for wound healing and pain relief, RLT devices—ranging from handheld panels to full-body beds—have grown in popularity for various conditions.
Key features of RLT:
RLT is thought to work by:
Reduced blood flow in PAD leads to tissue oxygen deprivation, causing pain and limiting mobility. RLT may address these issues through several mechanisms:
Vasodilation
Enhanced Cellular Energy
Anti-Inflammatory Effects
Tissue Repair and Regeneration
While research on red light therapy for peripheral artery disease is still emerging, several studies suggest potential benefits:
What the evidence tells us:
If you're considering RLT for PAD leg pain, keep the following in mind:
Choose the Right Device
Determine Treatment Parameters
Target Key Areas
Monitor Your Response
Combine with Other Strategies
Red light therapy is generally considered safe, but it's important to follow guidelines:
Always read the device manual, adhere to recommended doses, and stop treatment if unusual pain or skin reactions occur.
While RLT offers promise for easing PAD leg pain, it's not a standalone cure. Managing peripheral artery disease requires a comprehensive plan:
Lifestyle Changes
Medical Management
Ongoing Assessment
Never ignore new or worsening symptoms. If you experience sudden severe leg pain, signs of infection (redness, swelling, discharge), or symptoms suggestive of heart attack or stroke, seek immediate medical attention.
Discuss any new treatment—like red light therapy for peripheral artery disease—with your healthcare provider to ensure it fits your overall care plan and to rule out contraindications.
Red light therapy shows encouraging potential to improve circulation, reduce inflammation and ease leg pain in people with PAD. By targeting blood vessel function and cellular health, RLT can be a valuable addition to exercise, medications and lifestyle modifications. However, it's essential to:
Taking the first step toward understanding your symptoms is easy—try Ubie's free Arteriosclerosis Obliterans symptom checker to get personalized insights in just a few minutes. And always speak to a doctor about anything that could be life-threatening or serious. With the right plan, you can take proactive steps toward better circulation and less leg pain.
(References)
* Huang Y, Tang B, Deng H, et al. Photobiomodulation Therapy for Peripheral Artery Disease: A Systematic Review. Biomedicines. 2023 Sep 8;11(9):2489. doi: 10.3390/biomedicines11092489. PMID: 37703358; PMCID: PMC10529895.
* Chen AC, Huang YY, Hamblin MR. Photobiomodulation for Peripheral Arterial Disease: A Review. Cells. 2022 Jul 26;11(15):2326. doi: 10.3390/cells11152326. PMID: 35928828; PMCID: PMC9364860.
* Takiya CM, Martins CPB, Dourado HFS, et al. Photobiomodulation as an adjuvant therapy in the treatment of peripheral arterial disease: a systematic review. Lasers Med Sci. 2024 Feb 23;39(1):124. doi: 10.1007/s10103-024-04022-y. PMID: 38392113.
* Cury SS, Leite PM, Paiva AM, et al. Photobiomodulation therapy for improving microvascular function and walking performance in patients with peripheral artery disease: a pilot study. Lasers Med Sci. 2020 Dec;35(9):1989-1995. doi: 10.1007/s10103-020-03138-0. Epub 2020 Sep 21. PMID: 32959666.
* Loo MK, Teoh SL, Abdullah N. Low-level laser therapy for the treatment of diabetic foot ulcers and peripheral arterial disease: a systematic review. J Lasers Med Sci. 2021 Apr 19;12:e21. doi: 10.34172/jlms.2021.21. PMID: 33927453; PMCID: PMC8075308.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.